This is a demo store. No orders will be fulfilled.

Tabrecta or Rahika (Capmatinib)150mg x 60 Tablets

Tabrecta (Capmatinib) 150mg is a targeted therapy designed for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 alterations.

In stock

SKU
Tabrecta or Rahika 150mg x 60 Tablets
USD $3,700.00
Write Your Own Review
You're reviewing: Tabrecta or Rahika (Capmatinib)150mg x 60 Tablets
Your Rating:
Quality
Value
Price
loader
Loading...

You submitted your review for moderation.